Author

Yingzhuo Liu

Department of Cardiothoracic Surgery, Weill Cornell MedicineORCID 0009-0007-6120-8023Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

Andre Luis MoreiraiD· 1 shared Aristotelis TsirigosiD· 1 shared Benjamin G. NeeliD· 1 shared Bo XiaiD· 1 shared Cynthia A. LoomisiD· 1 shared David FenyöiD· 1 shared Dingcheng GaoiD· 1 shared Harvey Ira PassiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andre Luis MoreiraORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyNature Biomedical EngineeringPeer-reviewedFeb 20, 2025

Characterization of tumor heterogeneity through segmentation-free representation learning

Jimin Tan, Hortense Le, Jiehui Deng…·David Fenyö

The paper introduces a segmentation-free vision transformer, CANVAS, to discover and characterize tumor microenvironment signatures from high-dimensional multiplexed images, identifying a monocytic signature linked to poor prognosis.

10 citations

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologybioRxivJun 28, 2023

Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer.

Yi Ban, Yue Zou, Yingzhuo Liu…·Dingcheng Gao

This study identifies ribosome biogenesis as a key driver of EMT/MET transitions in breast cancer and shows that targeting this pathway enhances chemotherapy efficacy against chemoresistant tumors.

DOI 10.7554/elife.89486.3

humanscRNA-seq

𝕏 PostBluesky